Inspire Medical Systems (INSP) Net Income towards Common Stockholders (2017 - 2026)

Inspire Medical Systems has disclosed Net Income towards Common Stockholders across 10 years of filings, most recently posting $314000.0 for Q2 2026.

• In Q2 2026, Net Income towards Common Stockholders rose 108.74% year-over-year to $314000.0; the TTM figure through Jun 2026 stood at $135.0 million (up 154.22% YoY), while the FY2025 annual figure was $145.4 million, up 171.77% from the prior year.
• Net Income towards Common Stockholders came in at $314000.0 for Q2 2026 at Inspire Medical Systems, up from -$11.3 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $136.1 million in Q4 2025 to a low of -$16.8 million in Q3 2022.
• Average Net Income towards Common Stockholders over 5 years is $6.8 million, with a median of -$1.6 million recorded in 2025.
• Year-over-year, Net Income towards Common Stockholders soared 367.84% in 2023 and plunged 477.47% in 2026.
• Over 5 years, Net Income towards Common Stockholders stood at $3.2 million in 2022, then jumped by 367.84% to $14.8 million in 2023, then soared by 138.11% to $35.2 million in 2024, then surged by 286.36% to $136.1 million in 2025, then tumbled by 99.77% to $314000.0 in 2026.
• Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were $314000.0 in Q2 2026, -$11.3 million in Q1 2026, and $136.1 million in Q4 2025.